This study is designed to investigate the effects of a beta-adrenergic antagonist
(Propranolol; 40 mg IR) and nicotine patch (14 mg) administered alone and in combination on
neurobiological and behavioral responses to smoking cues in ongoing cigarette smokers. This
is a basic experimental study in humans and participants will not take these medications for
an extended period or make a cessation attempt as part of their involvement in this research
project.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oklahoma
Collaborators:
Duke University National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH) Oklahoma State University Center for Health Sciences